Using magnets to control chemical reactions that target release of medicines inside

first_img(—A team of researchers with the University of Georgia in Athens has developed a technique for controlling chemical reactions that release drugs inside the body. In their paper published in the journal Nature Catalysis, the group describes coating chemicals to prevent a reaction from occurring until the application of a magnetic field that releases a desired drug. In some medical applications, it is better for a medical treatment if a chemical can be applied directly to a certain part of the body and nowhere else. Chemicals meant to treat tumors are the prime example—chemotherapy drugs act on every cell they contact, causing a host of negative side effects. In this new effort, the group took a novel approach to solving this problem, using a magnet to force coated chemicals together, prompting a drug releasing reaction.To provide a means for controlling when chemicals come into contact inside the body, the researchers created tiny packets by first coating iron oxide nanoparticles with silica and then coating them further with two types of polymers, which, when combined, form a brush-like structure. Each of the packets was then loaded with either an enzyme or a substrate meant to react with the enzyme, and, of course, the drug to be released. In practice, the packets would be released into the body of a patient, where they would make their way to the whole body, behaving harmlessly, as the brushes prevent them from reacting whenever they meet. When the packets made their way to a site where a reaction was wanted, the researcher applied a magnet that forced them close together—close enough that they could react, releasing the drug. The other packets not involved in the reaction would slowly be flushed out of the body naturally, without causing harm.The researchers tested their packets in vitro using a real chemotherapy drug and cancer cells. They report it worked just as they had envisioned. More testing is required, of course, to ensure the technique is safe, but if all goes well, it could eventually be used to treat a wide variety of cancers. Multi stimuli-responsive nanocapsules selectively deliver drugs to exactly where they are needed Journal information: Nature Catalysis Explore further E- and S-type superparamagnetic nanoparticles carrying the enzyme and the substrate. a,b, Cryo-transmission electron microscopy (cryo-TEM) image (a) and schematic (b) explaining the concept of the magnetic-field-triggered biocatalysis. The particle superparamagnetic core is made of Fe3O4 nanoparticles enveloped by silica. The silica envelope is labelled with covalently bound fluorescent dyes (red for E-particles and green for S-particles). In the magnetic field, due to dipole–dipole interactions, the particles are brought into contact, so that the brush-like double-layer shells merge and intertwine, enabling interactions between the enzyme and substrate. The inner layers of the brush-shell are made of polyacrylic acid (PAA), which carries conjugated molecules of enzymes and substrates and provides the acidic environment for hydrolytic reactions. The external shell of poly(ethylene glycol methyl ether acrylate) polymer (PPEGMA) secures a barrier function to block ‘unauthorized’ or premature reactions of the enzyme and the substrate. The biocatalytic reaction is localized within the biocatalytic nanocompartment, which is generated in the magnetic field. The reaction is monitored by detecting the released cargo molecules. Credit: (c) Nature Catalysis (2017). DOI: 10.1038/s41929-017-0003-3last_img

Leave a Reply

Your email address will not be published. Required fields are marked *